The protein expression of HIF-1α, measured as the percentage of tumor cells displaying nuclear positivity, was not significantly different regarding RCC patients’ sex, type of tumor removal surgery, macroscopic or microscopic tumor extension, clinical stage, nuclear grade, or the presence of tumor necrosis (Table 2). This evidence concerns the gene HIF1A and renal cell adenocarcinoma.